KEYTRUDA plus Padcev improves survival for bladder cancer patients
Robert M. Williams Jr., a ten percent owner of Aveanna Healthcare Holdings , Inc. (NASDAQ:AVAH), has recently sold shares of the company. The transactions, which took place on April 1 and April 2, 2025, involved the sale of shares at a price of approximately $5.63 each. The timing is notable as AVAH shares have shown remarkable strength, delivering a 112.8% return over the past year, according to InvestingPro data.
The sales were executed through multiple transactions and resulted in a total sale value of $114,424. Following these transactions, Williams, acting through entities including J.H. Whitney VII, L.P. and PSA Healthcare Investment Holding LLC, continues to hold a significant number of shares indirectly. With a market capitalization of $1.04 billion and a "GREAT" Financial Health Score from InvestingPro, the company maintains a solid market position.
The sales were conducted under a pre-established Rule 10b5-1 trading plan, which was adopted in December 2024. This plan allows insiders to set up a predetermined schedule for selling shares, helping to avoid potential accusations of insider trading.
Investors and analysts often closely monitor such insider transactions as they can provide insights into the executive’s view on the company’s future performance.
In other recent news, Aveanna Healthcare Holdings Inc. reported stronger-than-expected financial results for the fourth quarter of 2024. The company achieved earnings per share of $0.05, surpassing the forecasted loss of $0.003, and reported revenue of $519.9 million, exceeding the anticipated $499.07 million. Additionally, Aveanna announced its agreement to acquire Thrive Skilled Pediatric Care, a move expected to expand its services into two new states and enhance its market presence. Moody’s Ratings affirmed Aveanna’s Caa1 rating and revised its outlook to positive, citing improvements in business performance and a decrease in leverage. UBS updated its price target for Aveanna to $4.50 while maintaining a Sell rating, reflecting ongoing concerns despite some positive changes. In leadership news, Dr. Sheldon Retchin resigned from Aveanna’s Board of Directors due to personal health reasons, with no immediate plans for a successor disclosed. These developments indicate significant changes and potential growth for Aveanna Healthcare.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.